GlassScriptPhysician profile
Paulinder S Rai
NPI 1568604478
$8,798.40
in general payments reported to CMS, 2019-2025
27 companies · $764 in 2025
The $764 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,685 · 2020: $536 · 2021: $1,343 · 2022: $803 · 2023: $676 · 2024: $992 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,432.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,227.89 | 2019 | |
| Smith+Nephew, INC. | $1,331.40 | 2019-2025 | Collagenase Santyl, Renasys Touch, Grafix Pl |
| Organogenesis INC. | $1,146.72 | 2019-2025 | Apligraf, Puraply, Puraply Wound Matrix |
| Abbvie INC. | $591.21 | 2021-2025 | |
| Tactile Systems Technology INC | $466.45 | 2020-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Misonix INC | $433.76 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $340.06 | 2019-2025 | Dysport |
| Medtronic, INC. | $339.40 | 2021-2024 | Cd Horizon Spinal System, Intellis Adaptivestim |
| Kci USA, INC. | $260.91 | 2019-2021 | |
| Urovant Sciences INC | $249.18 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $244.54 | 2021 | |
| Avanir Pharmaceuticals, INC. | $242.63 | 2019 | |
| Bioventus LLC | $151.94 | 2022-2023 | |
| Abbott Laboratories | $136.25 | 2019 | |
| Convatec INC. | $106.77 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $96.05 | 2023 | Nuplazid |
| Ossur Americas, INC. | $73.12 | 2025 | Navii |
| Alfasigma USA, INC. | $64.12 | 2021 | |
| Integra Lifesciences Corporation | $56.08 | 2020-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Allergan, INC. | $42.84 | 2019 | |
| Hydrofera LLC | $37.77 | 2023-2024 | Hydrofera Blue |
| Tei Medical INC. | $32.89 | 2019 | |
| Microtransponder, INC. | $31.73 | 2024 | |
| Lifenet Health | $30.71 | 2023 | |
| Arbor Pharmaceuticals, INC. | $24.31 | 2021 | |
| Grt US Holding, INC. | $19.92 | 2022 | |
| Paratek Pharmaceuticals, INC. | $19.75 | 2023 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paulinder Rai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.